Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
YMKYCgUR86XWw1JY